KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:待检查

Correction: Mirikizumab as Induction and Maintenance Therapy in Chinese Patients with Ulcerative Colitis: A Subpopulation Analysis of the Randomized, Global Phase 3 LUCENT-1 and LUCENT-2 Trials.

Zhihua Ran, Yan Chen, Yinglei Miao, Yufang Wang, Xiang Gao, Jie Zhong, Xueli Ding, Chengdang Wang, Xiaolan Zhang, Yijuan Ding, Naizhong Hu, Dan Tang, Jiao Yu, Chenxi Qian, Jun Shen

BioDrugs 40(4) 759-761

PMID42380713
PMCIDPMC13337907
DOI10.1007/s40259-026-00793-x
发表日期2026-07-01
AI 判定该论文不进入自动 KM 提取:This is a correction to a primary publication, not the original trial report. The abstract is empty, and the publication type is 'Published Erratum', which lacks primary data or results.
摘要

摘要

无摘要

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。